[an error occurred while processing this directive]
Research Management Group (RMG)

Cancer Funding Funding Opportunities



Index of cancer-related funding opportunities





 

 




INternal stanford funding opportunities and training programs

 

Internal Stanford Funding Opportunities
Webpage >>

 

 

 

Liimted submission program

 

 

Curing Kids Cancer
Innovation Research Award

Limited to 2 applicants
Amount of funding: Two types of one-year grants will be awarded:
Collaborative: One multi-institutional collaborative grant award of $300,000.
Individual: Two individual grant awards of $150,000 each.
Eligibility: Stanford faculty with PI eligibility or CE faculty (with an approved CE faculty PI waive).
Purpose: The goal of these grants is to overcome barriers to clinical application of new treatment approaches for childhood cancer. A priority is to fund projects that have already shown great promise, but that have a specific funding need to move forward. Applications to fund correlative studies associated with clinical trials in the focus areas will be considered.
Research Focus Areas (required): Cancer immunotherapy/Targeted therapy; High-grade brain tumor; Therapeutic targeting through genomics/epigenetics.
Internal Stanford Cancer Institute deadline: July 22, 2019, 3 p.m.
Internal Submission Guidelines:
https://med.stanford.edu/rmg/funding/curing_kids_cancer.html

 

 

 

Foundation and association-upcoming RFPs

 

 

 

 

American Association for cancer research (AACR)

 

 

American Association for Cancer Research
Stand up to Cancer Gastric Cancer Interception Research Team Award
Amount of funding: 
up to $3 million in funding over a three year grant term.
Purpose:  The Stand Up To Cancer Gastric Cancer Interception Research Team Grant represents a new, focused effort to implement advances in gastric cancer interception and prevention research as rapidly as possible through the creation of a collaborative, translational, cancer “Research Team”. The most talented and promising researchers across institutions will be assembled into a Research Team, forming an optimal configuration of expertise needed to solve key problems in gastric cancer interception and prevention research. This Research Team will span multiple disciplines within and beyond the gastric oncology community, ideally including investigators with expertise outside the biological sciences, and utilize new tools to answer research questions in a coordinated way.
Eligibility:  Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver obtained through their RPM at least 1-2 weeks prior to the LOI submission).
- Each Team will consist of a Team Leader, a Team Co-leader, no more than four additional Principals, a Project Manager, and at least two Advocates, with no more than six but a minimum of two participating institutions. Each Team must designate at least a Leader and a Co-Leader who must be from different institutions.
-To maximize creativity, innovation, and collaboration, the Research Team key personnel must include laboratory and clinical researchers, including both senior and early career investigators, who have not necessarily worked together in the past. 
No citizenship requirement.
Timeline: 
Expression of intent (required) deadline: July 30, 2019, 12pm ET 
If invited to submit a full proposal:
Best practice-SoM PIs- please submit the required Proposal Intake Form in SeRA one month prior to the sponsor’s deadline
Institutional representative (RPM/RMG) deadline: August 23, 2019
Full proposal (by invitation only) deadline:  August 30, 2019
Please review the AACR funding opportunity here.
Download a PDF file of the program guidelines and application instructions here.
The Expression of Intent Document is available here.

 

 

 

 

 

 



American Cancer Society- 2019




The following ACS RFPs are also posted on the ACS proposal central webpage >>
ACS introductory webpage >>

Citizenship: applicants for Clinician Scientist Development Grant and Postdoctoral Fellowships must at the time of application be United States citizens or permanent residents of the United States. There are no U.S. citizenship requirements for all other grants. 

 





American Cancer Society (ACS)
Melanoma Research Alliance (MRA)
Understanding and Managing Metastasis in Melanoma
Letter of intent required deadline was  Jan. 16, 2019 via proposal central
Guidelines


American Cancer Society 
Research Professor Grant
$80K/yr direct costs for 5 years (2 to be awarded) 
Eligibility: mid-career faculty with PI eligibility who have made seminal contributions that have changed the direction of basic cancer research. 
No citizenship requirement (see page 8 in the guidelines) 
Letter of intent (required) deadline: Feb. 1, 2019* via proposal central
*you do not have to submit your LOI through your RPM.
If invited to submit a full proposal:
SoM PIs-please submit a Proposal Intake Form (PIF) in SeRA asap
Institutional representative (RPM/RMG) deadline:  March 25, 2019
Full proposal: April 1, 2019 via proposal central
Guidelines >>

 

 

American Cancer Society
Mission Boost Grant
Primary Mission Boost 
– A maximum $100,000 Direct plus 20% Indirect costs per year may be requested for up to 2 years (Total: $240,000).
Secondary Mission Boost – A maximum of $300,000 Direct plus 20% Indirect costs (Total: $360,000) may be requested for up to 18 months.
Mission Boost Grants (MBG) are opportunities for ACS grantees to seek additional, or “boost,” resources for innovative, high-risk/high-reward projects.
MBGs offer 2 stages of funding: The Primary Boost, the Secondary Boost.  See the RFP for amount of funding.
Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver) who:
-have held or currently hold one of these grants (or previous versions of such awards): Research Scholarship Grant (RSG), Mentored Research Scholar Grant (MRSG), Cancer Control Career Development Awards (CCCDA), or Pilot and Exploratory Projects in Palliative Care (PEP) award.
-have held one of the above ACS grants for a minimum of 1 year. 
Note: For current ACS grantees, we recommend delaying submission of letter of intent (LOI) until the last year of the grant since part of the LOI review may include consideration of discoveries made under ACS support.
-and who are currently independent, full-time faculty at a not-for-profit, US-based research institution that has facilities and support to enable preclinical and clinical studies.
Not eligible: people who have had only grants for ACS Postdoctoral Fellows or ACS Professors, without also having one of the grant types listed above.
Letter of intent (required) deadline:  March 1, 2019  via proposal central
If invited to submit a full proposal:
SoM PIs-please submit a Proposal Intake Form (PIF) in SeRA asap
Institutional representative (RPM/RMG*) deadline: July 8, 2019
Full proposal (by invitation only) deadline:  July 15, 2019  via proposal central
Guidelines >>
https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/mission-boost-grants.html



ACS Institutional grants (not individual awards)

 

American Cancer Society
Institutional Research Grant (IRG)

Institutional Research Grants (not individual awards) are block grants averaging $120,000 per year for 3 years given to institutions as "seed money" for the initiation of projects by promising junior investigators.  These grants are renewable.
Eligibility: faculty with PI eligibility.  (Dr. Steve Artandi, the Director of the Stanford Cancer Institute will designate the PI)
See pages 22-24 in the RFP for additional information
Institutional representative (RPM/RMG) deadline:  March 25, 2019
Full proposal: April 1, 2019 via proposal central
Overview webpage >>
https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant/grant-types/institutional-research-grants.html
Download a PDF file of the guidelines >>



American Cancer Society
Physician Training Award in Cancer Prevention

A two-year institutional training program (not an individual award) to support physician training in accredited preventive medicine residency programs that provide cancer prevention and control research and practice opportunities. Awards are made for 4 years in the total amount of $300,000 based on an average of $50,000 per resident training year. 
Eligibility:   faculty with PI eligibility (Dr. Steve Artandi, the Director of the Stanford Cancer Institute will designate the PI)
See pages 21-25 in the RFP for additional information
Institutional representative (RPM/RMG) deadline:  March 25, 2019
Full proposal: April 1, 2019 via proposal central
Overview webpage >>
Download a PDF file of the guidelines >>

 

 

 

 

ACS Individual Research Grants

 

American Cancer Society
Clinician Scientist Development Grant
Awards range from 3 to 5 years, for a maximum $135,000 Direct costs, plus 8% allowable indirect costs per year. The mentor(s) receive a maximum of $10,000 per year (regardless of the number of mentors). That amount is included in the $135,000
This RFP fosters the development of clinicians to clinician scientists. Clinician scientists are investigators licensed to provide patient care and trained to conduct research. They pursue research questions across the cancer research continuum of relevance to improving health.
Eligibility: Applicants must be full-time (faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver) and within the first 6 years of their initial faculty appointment. (See pages 21- 25 the RFP for additional criteria and other funding restrictions)
**Not eligible:  Instructors, Clinical Instructors, Academic staff-research (i.e., research associates) are not eligible because Stanford does not consider those positions to be independent or faculty-level appointments.
Citizenship: applicants for Clinician Scientist Development Grant and Postdoctoral Fellowships must at the time of application be United States citizens or permanent residents of the United States. There are no U.S. citizenship requirements for all other grants. (See page 8 in the RFP.)
Institutional representative (RPM/RMG) deadline:  March 25, 2019 and Oct. 8, 2019
Full proposal: April 1, 2019 and Oct. 15, 2019 via proposal central
Overview webpage >>
Download a PDF file of the guidelines >>

 

 

American Cancer Society 
Pilot and Exploratory Projects in the Palliative Care of Cancer Patients and their Families
$60K direct costs per year plus 20% indirect costs for up to 2 years
Supports investigators performing pilot and exploratory research studies that test interventions, develop research methodologies, and explore novel areas of research in palliative care of cancer patients and their families. See the webpage for the 3 focus areas.
(See pages 21-23 for additional information.)
Eligibility:  independent investigators-Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver) with M.D. or PhD. degrees at any level may apply. Applicants must have a full-time faculty position.
*Not eligible:  Instructors, Clinical Instructors, Academic staff-research (i.e., research associates) are not eligible because Stanford does not consider those positions to be independent or faculty-level appointments.
(Submit via the Pilot and Exploratory grant mechanism)
No citizenship restriction (see page 8 in the guidelines)
Institutional representative (RPM/RMG) deadline:  March 25, 2019 and Oct. 8, 2019
Full proposal: April 1, 2019 and Oct. 15, 2019 via proposal central
Overview webpage >>
Download a PDF file of the guidelines >>

 

 

Research Scholar Grants (3 types)

 

American Cancer Society
Research Scholar Grants 
RSG in Basic, Pre-clinical Clinical, Epidemiology, Psychosocial and Behavioral Research and Research in Palliative Care and Symptom Management 
(see the RSG chart on pages 21-22 and the overview on pages 21-26 of the guidelines)
Amount of funding: $165K direct costs plus 20% indirects per year for up to 4 yrs. 
Eligibility: Assist. prof. with PI eligibility and CE assist. prof. (with an approved PI waiver) who are independent investigators within the first 6 years of independent career, within a total of 12 years from the awarding of the terminal degree, and with no more than 1 current R01[-like] grant. Eligibility is extended to 8 years for clinician scientists who remain active in clinical care.
*Not eligible:  Instructors, Clinical Instructors, Academic staff-research (i.e., research associates) are not eligible because Stanford does not consider those positions to be independent or faculty-level appointments.
No citizenship restriction (see page 8 in the guidelines)
Institutional representative (RPM/RMG) deadline:  March 25, 2019 and Oct. 8, 2019
Full proposal: April 1, 2019 and Oct. 15, 2019 via proposal central
Overview webpage >>
PDF file of the guidelines >>

 

American Cancer Society
Research Scholar Grant
RSG in Cancer Control: Health Policy and Health Services Research 
(see the RSG chart on pages 21-22 and the overview on pages 21-26 of the guidelines)
Amount of funding: $165K direct costs plus 20% indirects per year for up to 4 yrs. 
Eligibility:   Independent* investigators at any stage of their career with any level of funding-Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Not eligible:  Instructors, Clinical Instructors, Academic staff-research (i.e., research associates) are not eligible because Stanford does not consider those positions to be independent or faculty-level appointments.
No citizenship restriction (see page 8 in the guidelines)
Institutional representative (RPM/RMG) deadline:  March 25, 2019 and Oct. 8, 2019
Full proposal: April 1, 2019 and Oct. 15, 2019 via proposal central
Overview webpage >>
Download a PDF file of the guidelines >>

 

 

American Cancer Society
Research Scholar Grant
RSG in the Role of Health Policy and Health Insurance in Improving Access to Care and Performance in Cancer Prevention, Early Detection, and Treatment Services
(see the RSG chart on pages 21-22 and the overview on pages 21-26 of the guidelines)
Amount of funding for insurance studies: up to $200K direct costs plus 20% indirects per year for up to 5 yrs. 
Eligibility:   Independent* investigators at any stage of their career with any level of funding-Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Not eligible:  Instructors, Clinical Instructors, Academic staff-research (i.e., research associates) are not eligible because Stanford does not consider those positions to be independent or faculty-level appointments.
No citizenship restriction (see page 8 in the guidelines)
Institutional representative (RPM/RMG) deadline:  March 25, 2019 and Oct. 8, 2019
Full proposal: April 1, 2019 and Oct. 15, 2019 via proposal central
Overview webpage >>
Download a PDF file of the guidelines>>

 

 

American Cancer Society
Research Scholar Grant
RSG in Priority Program of Cancer Control: Health Disparities Research
(see the RSG chart on pages 21-22 and the overview on pages 21-26 of the guidelines)
Amount of funding: $165K direct costs plus 20% indirects per year for up to 4 yrs: Exception: $400K per year for up to 5 years-- only if study is population based and focused on achieving health equity  (see description below the chart on page 23)
Eligibility:  Independent* investigators at any stage of their career with any level of prior funding.  Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
*Not eligible:  Instructors, Clinical Instructors, Academic staff-research (i.e., research associates) are not eligible because Stanford does not consider those positions to be independent or faculty-level appointments.
No citizenship restriction (see page 8 in the guidelines)
Institutional representative (RPM/RMG) deadline:  March 25, 2019 and Oct. 8, 2019
Full proposal: April 1, 2019 and Oct. 15, 2019 via proposal central
Overview webpage >>
Download a PDF file of the guidelines >>

 

 

Postdoctoral fellowship

 

American Cancer Society
Postdoctoral Fellowship
Individuals may apply for one, two- or three-year fellowships.
Awards may be for up to three years with progressive stipends of $48,000, $50,000, and $52,000 per year, plus a $4,000 per year fellowship allowance.
Eligibility*:  individuals who have held a Ph.D. or M.D. for more than 4 years at the time of the application are generally not eligible for a Fellowship (see the RFP).  See the exceptions re: exempt training and leave of absence.
Citizenship requirement:  applicants for Postdoctoral Fellowships and the Clinician Scientist Development Grant must at the time of application be United States citizens or permanent residents of the United States. There are no U.S. citizenship requirements for all other grants.
Institutional representative (RMG Fellowship Office*) deadline: March 25, 2019 and Oct. 8, 2019
Full proposal: April 1, 2019 and Oct. 15, 2019 via proposal central
Guidelines >>
Download a PDF file of the guidelines >>
*Institutional representative: RMG Fellowship Office per the proposal checklist on this webpage >>

 

 



ACS Clinical Research Professor Grant-to be updated with 2019 deadline

 

American Cancer Society
Clinical Research Professor
$80K /yr. for 5 yrs ($400,000 total) - this may be renewed once)
Eligibility:  Applicants who have held the rank of full professor (with PI eligibility) for more than 15 years 
and who have made seminal contributions in the area of cancer control that have changed the direction of clinical, psychosocial, behavioral, health policy or epidemiological cancer research.
Letter of intent (required) deadline:  Aug. 1 TBA via proposal central
If invited to submit full proposal alert your RPM asap:
Institutional representative (RPM/RMG) deadline: 5-working days prior
Full proposal (by invitation only) deadline:  Oct. 15 TBA via proposal central
Guidelines >>
2019 RFP TBA
Institutional representative: you do not need to submit your LOI through your RPM for their approval, you can submit it directly to proposal central.


ACS International Program

American Cancer Society
Audrey Meyer Mars International Fellowships in Clinical Oncology
Amount of funding:  up to US $65,000 for one year.
See page 3-4 of the RFP for applicant eligibility.
This program is limited to non-US citizens and provides support for one year of advanced training in clinical oncology at participating US cancer centers to qualified physicians and surgeons from other countries, particularly countries where advanced training is not readily available.
Note: Sponsoring institutions must submit the AMM application to the American Cancer Society on behalf of the accepted candidate.
Full proposal deadline:  Oct. 15 TBA via proposal central
Overview webpage >>

 

 

 

 

 

 

 

 

Breast cancer

 

 

Susan G. Komen
Career Catalyst Research Grant
Amount of funding: $450,000 combined direct and indirect costs; ($150,000 per year for up to 3 years)
The focus area for the FY20 Career Catalyst Research Award is Redefining Metastatic Breast Cancer Through Liquid Biospy. The goal of the FY20 CCR Grant is to support outstanding research seeking to use liquid biopsy techniques to improve treatment, detection, and understanding of metastatic breast cancer.  See the guidelines for additional information. These awards seek to bridge the funding gap faced by faculty as they start their careers in breast cancer research. Applications that fit the focus area as detailed above and include studies that address metastatic breast cancer disparities, or leverage data science to better understand and treat metastatic breast cancer are highly encouraged
Eligibility:
-Must have a doctoral degree, including M.D., Ph.D., Dr.P.H., D.O., or equivalent.
-Must currently hold a full-time faculty appointment or have a formal offer letter from the Institution that confirms position and start date by the Application due date (Sept. 25, 2019), documented by the Applicant/PI Biosketch and Letter of Institutional Support. No citizenship restriction.
Stanford eligibility clarificationAssist. Prof. with PI eligibility and CE Assist. Prof. (with an approved PI waiver obtained through their RPM at least 1-2 weeks prior to the LOI submission) who have not held any faculty appointment for more than a total of 8 years by the Application due date (Sept. 25, 2019) 
Other funding restriction: Must not currently be or have been a Principal Investigator on an existing NIH R01 grant or their equivalent as of the date of Award Notification (April 15, 2020). 
No citizenship requirement
Not eligible: Instructors, Clinical Instructors, Academic staff-research (i.e., research associates) are not eligible because Stanford does not consider these positions to be independent or faculty level positions.
Timeline:
Letter of intent (required) deadline: July 10, 2019via proposal central
Enter the name of your RPM in as business official in your letter of intent submission.
If invited to submit a full proposal:
SoM PIs- please submit your required Proposal Intake Form (PIF) in SeRA at least a month prior to the sponsor’s deadline.
Institutional representative (RPM/RMG) deadline: Sept. 18, 2018
Full proposal by invitation only: Sept. 25, 2019 via proposal central
To display the RFP, click on the “pink” RFP title block:
https://ww5.komen.org/ResearchGrants/FundingOpportunities.html
Download a PDF file of the RFP

 

 

 

 

 

Childhood cancer

 

 

 

 

The Andrew McDonough B+ Foundation
Childhood Cancer Research Grant
Amount of funding: $75K per year for 2 years ($150K total).
Purpose: The initiative aims to reduce harm from erroneous or delayed diagnoses, reduce costs and redundancy in the diagnostic process, improve health outcomes and save lives. The The B+ Foundation, with the help of a highly respected Scientific Advisory Board, funds cutting-edge childhood cancer research.  The B+ Foundation funds grants that support basic, translational or clinical research, which may lead towards cures and better treatments for childhood cancers. 
Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Timeline:
SoM PIs: submit your required Proposal Intake Form (PIF) form in SeRA asap
Institutional representative (RPM/RMG) deadline: September 6, 2019
Full application deadline: September 13, 2019 via proposalCENTRAL
Sponsor website: https://bepositive.org/
Guidelines may be downloaded from the proposalCENTRAL webpage by selecting the text icon next to “Childhood Cancer Research Grant”.

 

CureSearch for Children’s Cancer
Acceleration Initiative Award in Pediatric Cancer
Amount of funding: $1.5M over 3 years (including 10% indirects).
Purpose: The AI-5 solicitation is requesting translational projects aiming to bring technologies toward preclinical and clinical studies that address areas of high unmet need and will lead to therapies for children within a three-year timeframe. Applicants are encouraged to identify a challenge area pediatric cancer drug development and describe how their proposal will address the challenge and overcome critical barriers to pediatric oncology treatment. 
Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Timeline:
Letter of intent (required) deadline: July 19, 2019via proposal central
Enter the name of your RPM in as business official in your letter of intent submission.
If invited to submit a full proposal:
SoM PIs: submit your required Proposal Intake Form (PIF) form in SeRA asap
Institutional representative (RPM/RMG) deadline: October 8, 2019
Full application deadline: October 15, 2019 via proposalCENTRAL
Sponsor website: https://curesearch.org/Acceleration-Initiative
Guidelines may be downloaded from the proposalCENTRAL webpage by selecting the text icon next to “Acceleration Initiative Award in Pediatric Cancer”.

 

 

CureSearch for Children’s Cancer
Catapult Award: Clinical Trial Awards in Pediatric Cancer
Amount of funding: $2.5M over 3 years (including 10% indirects).
Purpose: To accelerate the development of novel, innovative, less-toxic treatments for children with cancer. The goal of the Catapult Award is to overcome barriers to pediatric cancer drug development by providing meaningful funding and expert scientific guidance in order to advance the development of promising oncology research out of the lab, into clinical trials and to regulatory approval, with the ultimate goal of improving clinical outcomes in childhood cancer patients and making new treatments widely available. 
Eligibility: Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Timeline:
Letter of intent (required) deadline: July 19, 2019via proposal central
Enter the name of your RPM in as business official in your letter of intent submission.
If invited to submit a full proposal:
SoM PIs: submit your required Proposal Intake Form (PIF) form in SeRA asap
Institutional representative (RPM/RMG) deadline: October 8, 2019
Full application deadline: October 15, 2019 via proposalCENTRAL
Sponsor website: https://curesearch.org/Catapult-Awards
Guidelines may be downloaded from the CureSearch for Childhood Cancer proposalCENTRAL webpage by selecting the text icon next to “Catapult Award: Clinical Trial Awards in Pediatric Cancer”.

 

 

CureSearch for Children’s Cancer
Young Investigator Awards in Pediatric Oncology Drug Development
Amount of funding: $75K over 3 years (including 10% indirects).
Purpose: CureSearch for Children’s Cancer supports the recruitment of promising early career scientists to a research career in pediatric oncology. The 2019 Young Investigator Program is designed to provide support and training for exceptional young investigators in pediatric oncology drug development. The award is intended for investigators who have completed post-doctoral training and are transitioning to a full-time academic position. 
Eligibility: Applicants must be MD (or equivalent), PhD, MD-PhD with no more than six years beyond completion of post-doctoral training 
Timeline:
Letter of intent (required) deadline: July 19, 2019via proposal central
Enter the name of your RPM in as business official in your letter of intent submission.
If invited to submit a full proposal:
SoM PIs: submit your required Proposal Intake Form (PIF) form in SeRA asap
Institutional representative (RPM/RMG) deadline: October 8, 2019
Full application deadline: October 15, 2019 via proposalCENTRAL
Sponsor website: https://curesearch.org/Young-Investigator-Program
Guidelines may be downloaded from the proposalCENTRAL webpage by selecting the text icon next to “Young Investigator Awards in Pediatric Oncology Drug Development”.

 

 

 

Alex’s Lemonade Stand for Childhood Cancer
2019 RUNX1 Early Career Investigator Grant Program
Amount of funding: 
$60,000 per year over 3 years (maximum of $180,000)
Purpose:  A research and advocacy venture committed to funding world-class, innovative and cross-disciplinary cancer research to develop a cure for RUNX1-FPD, a familial platelet disorder (FPD) with a predisposition to blood cancer. The program also aims to support, inform, educate and connect patients and healthcare providers in the RUNX1 community. This award aims to promote the establishment of a new generation of translational and clinical researchers interested in tackling inherited hematologic malignancy predisposition disorders with a focus on RUNX1-familial platelet disorder.
Eligibility:  Applicants must have an M.D., Ph.D. or dual M.D., Ph.D. (D.O., MBBS or equivalent) and be within 5 years of their first faculty appointment as an Assistant Professor or equivalent. 
Associate and Full Professors are ineligible. 
Not eligible: Stanford Instructors, Clinical Instructors, Academic Staff-research are not eligible because Stanford does not consider them to be independent or faculty level positions.
No citizenship requirement, but research must be done in institutions in Canada or the U.S.
Timeline: 
Best practice-SoM PIs- please submit the required Proposal Intake Form (PIF) in SeRA one month before the sponsor’s deadline
Institutional representative (RPM/RMG) deadline: June 20, 2019, Sept. 19, 2019, Dec. 18, 2019
Full proposal deadline:  September 26, 2019; December 26, 2019
ALSF Program overview webpage >>
Download a PDF file of the guidelines here.

 

 

 

 

GEneral cancer

 

 

 

 

Gordon and Betty Moore Foundation
Diagnostic Excellence Initiative
Request for Ideas for Clinical Measures to Improve Diagnosis

Amount of funding: $250,000 to $500,000 each for work done over 12-18 months (3-6 grants will be awarded)
Purpose: The initiative aims to reduce harm from erroneous or delayed diagnoses, reduce costs and redundancy in the diagnostic process, improve health outcomes and save lives. The foundation is soliciting novel ideas and approaches for developing new clinical measures to improve diagnosis, specifically targeting three major categories of diseaseacute vascular events (such as stroke and myocardial infarction), infections (such as sepsis and pneumonia) and cancer (such as lung and colorectal cancer).
Eligibility: Stanford faculty with PI eligibility (UTL, MCL, and NTLR appts) and CE faculty (with an approved CE faculty PI waiver)
Timeline:
Initial application deadline: August 2, 2019 via the online portal*
Semi-finalists will be announced by Aug. 23rd. A member of the semi-finalist team is required to participate in a one-day, in-person meeting at the foundation’s office in Palo Alto on Sept. 19th. Finalists will be invited in early October to submit full proposals
If invited to submit a full proposal:
SoM PIs: submit your required Proposal Intake Form (PIF) form in SeRA approximately one month prior to the sponsor’s deadline.
Institutional representative (RPM/RMG) deadline: Oct. 25, 2019
Full proposal deadline:  Nov. 1, 2019
Overview: https://www.moore.org/initiative-strategy-detail?initiativeId=diagnostic-excellence 
*Guidelines and link to online application portal: https://moore-patientcare.smapply.io/prog/request_for_ideas/

 

 

 

 

Lymphoma

 

 

 

 

Lymphoma Research Foundation
Clinical Investigator Career Development Award

Amount of funding: total of $225,000 over 3 years.
Purpose: The LRF Clinical Investigator Career Development Award (CDA) Program is designed to support physician investigators at the level of advanced fellow or junior faculty member who will contribute to the development of new lymphoma therapies and diagnostic tools. 
Eligibility: Stanford Assist. Prof. with PI eligibility, CE Assist. Prof. (with an approved PI waiver), and advanced fellows.
Applicants must be licensed physicians at a clinical research institution in the United States or Canada for the duration of the LRF grant, and intending to pursue a career in lymphoma clinical research.
Applicants for this award should be clinical physicians in one of the ACGME accredited specialties (e.g., hematology/oncology, pediatrics, pathology, dermatology, radiation oncology). 
The applicant must be an advanced fellow or junior faculty member with at least 2 years (24 months) of fellowship or postdoctoral training and no greater than 5 years of experience beyond completion of his/her fellowship or post doctoral training (the five year limit may be non-sequential) at the start of the award period (March 1, 2020). 
See other criteria and other funding restrictions.
No citizenship restriction.
Timeline:
SoM PIs: submit your required Proposal Intake Form (PIF) form in SeRA approximately one month prior to the sponsor’s deadline.
Institutional representative (RPM/RMG) deadline:  August 29, 2019
Full proposal deadline:  September 5, 2019 via proposalCENTRAL
Program guidelines and application instructions
Download a pdf file of the guidelines here.
Institutional representative for all PIs: this is a mentored career development grant. Please alert your department’s Research Process Manager (RPM in RMG) by submitting a PIF.

 

Lymphoma Research Foundation
Lymphoma Postdoctoral Fellowship Grant
Amount of funding: a total of $105,000 to grantees over two years.
Purpose: The LRF Postdoctoral Fellowship Grant is designed to support investigators at the level of advanced fellow or postdoctoral researcher in laboratory or clinic based research with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma, including chronic lymphocytic leukemia.
Eligibility: Applicants must hold an MD, PhD, or equivalent degree. MD Applicants must have completed at least two years (24 months) of their fellowship work at the start of the award period. All applicants should not have completed more than five years (60 months) of their fellowship or postdoctoral work at the start of their award period. Individuals holding faculty positions prior to March 1, 2020 are not eligible to apply; awarded applicants may move into faculty positions during the award period.
See the guidelines for other criteria.
No citizenship requirement.
Timeline:
SoM PIs: submit your required Proposal Intake Form (PIF) form in SeRA approximately one month prior to the sponsor’s deadline.
Institutional representative (RPM/RMG) deadline:  August 29, 2019
Full proposal deadline:  September 5, 2019 via proposalCENTRAL
Program guidelines and application instructions
Download a pdf file of the guidelines here.
Institutional representative for all PIs: this is a mentored career development grant. Please alert your department’s Research Process Manager (RPM in RMG) by submitting a PIF.

Lymphoma Research Foundation
Lymphoma Clinical Research Mentoring Program

A Training Program for Hematology/Oncology Fellows and Junior Faculty with a focus on Clinical Research in Lymphoma
The LRF Scientific Advisory Board will select up to 8 applicants to become LRF Scholars and participate in the Lymphoma Clinical Research Mentoring Program. LRF Scholars attend an initial LCRMP workshop which is four days in length. The workshop will take place March 3-7, 2020 in Scottsdale, AZ.
This is an education and mentoring program for fellows and junior faculty with a focus in clinical research in the field of non-Hodgkin and Hodgkin lymphoma, including chronic lymphocytic leukemia. The program is two years in length and offers a broad education on clinical research and career development as well as managing career and quality of life issues.
Eligibility: Stanford Assist. Prof. with PI eligibility and CE Assist. Prof. (with an approved PI waiver) within the first 4 years of a faculty position or trainees who are at least in their second year of the one of the ACGME accredited sub-specialty fellows programs: Hematology/oncology, Hematology, Medical Oncology, Radiation Oncology, or Hematopathology.
Timeline:
SoM PIs: submit your required Proposal Intake Form (PIF) form in SeRA approximately one month prior to the sponsor’s deadline.
Institutional representative (RPM/RMG) deadline:  August 29, 2019
Full proposal deadline:  September 5, 2019 via proposalCENTRAL
Program guidelines and application instructions
Download a pdf file of the guidelines here.
Institutional representative for all PIs: this is a mentored career development grant. Please alert your department’s Research Process Manager (RPM in RMG) by submitting a PIF.

 

 

 

 

Quality of life

 

 

 

Health and Environmental Sciences Institute (HESI)
HESI Thrive-Making Cancer Patient Quality of Life an Active Research Priority
Amount of funding
: $20K-$50K for up to 24 months (4-6 grants will be awarded)
THRIVE, a 2018 Biden Cancer initiative, seed grants for nonclinical, clinical, and translational research and technology-based solutions that enhance our ability to predict when and how adverse effects may occur in patients who have received cancer treatment. See the guidelines for additional information.
Eligibility- independent researchers- faculty with PI eligibility and CE faculty (with an approved CE Faculty PI waiver).  Applicants must hold a M.D., Ph.D., D.V.M. or equivalent degree.
Not eligible:  Instructors, Clinical Instructors, Academic staff-research are not eligible because Stanford does not consider those positions to be independent or faculty-level positions.
Timeline:
Letter of intent (required) deadline-extended: July 1, 2019
If invited to submit a full proposal:
SoM-PIs- 
please submit a Proposal Intake Form (PIF) form in SeRA asap
Institutional representative (RPM/RMG or CGO/OSR) deadline:  Sept. 19, 2019
Full proposal deadline:  Sept. 16, 2019
Guidelines:
http://hesithrive.org/guidelines/

\

 

 

 

 

 

 




Postdoctoral funding opportunities

     

     

Current announcements

 

 

Damon Runyon Cancer Research Foundation 
Damon Runyon Dale F. Frey Award for Breakthrough Scientists
Amount of funding: $100,000 over 1 year 
Purpose: Provides funding that enables postdoctoral fellows to complete their training under the mentorship of a leading senior scientist and encourages them to follow their own bold ideas. The program encourages new ideas to transform the way we prevent, diagnose and treat cancer. 
EligibilityDamon Runyon Fellows are eligible to apply in the fourth year of their Fellowship.  Currently, Damon Runyon Fellows selected in November 2015 and May 2016 (DRG-118-16, DRG-119-16, DRG-2243-16 to DRG-2280-16, DRSG-15P-16 to DRSG-18P-16) are eligible to apply.
No citizenship restriction.
Timeline:
Institutional representative (RPM/RMG) deadline: July 8, 2019 
Full proposal deadline: July 15, 2019
SoM PIs:  submit the required Proposal Intake Form (PIF) in SeRA asap
Program overview and application guidelines
Institutional representative: your Research Process Manager (RPM in RMG)

 

 

 

American Association for Cancer Research (AACR)
AACR-Cancer Research UK Transatlantic Fellowships
Amount of funding: 
U.S. to U.K. Successful applicants will receive $400,000 in total over 4 years
U.K. to U.S. Successful applicants will receive £300,000 in total over 4 years
Administering Institutions: This will be the institution in the home country of the applicant (either the U.S. or the U.K.), that will be managing the financial aspects of the award for the duration of the fellowship.
Research Host Institutions: These will be the institutions where the applicant will be undertaking research. The principal investigator with whom the applicants will be working will be the "Research Sponsor" and will be based at the Research Host institutions.
Purpose: The AACR-Cancer Research UK Transatlantic Fellowship is a four-year postdoctoral fellowship programme to support promising early stage postdoctoral researchers to pursue their projects both in the U.K. and the U.S. Funds provided through this mechanism will allow fellows to embark on research projects conducted at the best research environments in either the U.K. or the U.S. and will present a unique opportunity to forge international collaborations that will help these early career investigators to establish their independent research careers. 
Eligibility: Please see the guidelines for eligibility.
The Research Sponsor at the host institution is expected to be a recognized figure in the cancer field. No citizenship restriction.
Timeline:
Letter of intent (required) deadline:  July 25, 2019 via ProposalCentral
If invited to submit a full proposal:
Institutional representative (RPM/RMG) deadline: Oct. 2, 2019
Full proposal deadline (by invitation only) deadline:  Oct. 9, 2019 via ProposalCentral
Guidelines:
https://www.aacr.org/Funding/Pages/Funding-Detail.aspx?ItemID=91

 

 

Damon Runyon Cancer Research Foundation
Fellowship Award
See the guidelines for eligibility criteria
No citizenship restriction
NOTE: applicants can only apply to ONE, but not to both: Damon Runyon-Sohn Pediatric Cancer Fellowship Award fellowship award or the Damon Runyon Fellowship award
Institutional representative deadlines (RMG Fellowship Office): Aug. 8, 2019 and March 2020
Deadlines: Aug. 15, 2019 and March 2020
Eligibility guidelines:
http://www.damonrunyon.org/for_scientists/more/fellowship_award_overview
Fellowship application guidelines:
https://www.damonrunyon.org/for-scientists/application-guidelines/fellowship/forms
*Institutional representative: RMG Fellowship Office per the proposal checklist on this webpage >>

 

 

 

NIH Cancer funding opportunities

 

 

 

 

NIH Search Tool webpage (for current funding opportunities)

It’s best if you search using the drop down menu: “issuing” organization (i.e., by institute: NCI) because the search result will include a table of numerous (over 160+) current NCI FOAs:
http://grants.nih.gov/grants/guide/search_guide.htm




     

NIH investigator-initiated funding opportunities that NCI participates in (highlights)



Eligiblity: unless otherwise stated, Stanford faculty with PI eligiblity (those with UTL, MCL, NTLR faculty appointments) and CE faculty (with an approved CE faculty PI waiver request).


NIH Research Project Grant (Parent R01-Clinical Trial Not Allowed) PA-19-056
Multiple participating institutes (NCI participates in this FOA.)
Eligibility: faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Standard AIDS-related deadlines:   May 7, Sept. 7, Jan. 7
Expiration date:  Jan. 8, 2022
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-19-056.html
Table of Institute/Center Program Officer contacts (the webpage reflects the previous FOA#):
https://grants.nih.gov/grants/guide/contacts/parent_R01.html

NIH Research Project Grant (Parent R01 Clinical Trial Required) PA-19-055 
Note: NCI does not participate in this separate Parent R01 that requires a clinical trial.
https://grants.nih.gov/grants/guide/pa-files/PA-19-055.html

NCI does not participate in the Parent R03, Parent R21 grants. See below for the NCI investigator-initiated FOAs.

 

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) PAR-18-290
Purpose: the proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of at least three research projects and an Administrative Core. The projects must share a common central theme, focus, and/or overall objective.
Standard P award deadlines:  Jan. 25, May 25, Sept. 25
Standard AIDS-related deadlines:  May 7, Sept. 7, Jan. 7”
Expiration date:  Jan. 8, 2020
https://grants.nih.gov/grants/guide/pa-files/PAR-18-290.html


NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) PAR-18-020
Purpose: supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies--including the use of new clinically-relevant models and imaging technologies--which could lead to first-in-human clinical trials.
(REVISED) remaining deadline:  Feb. 20, 2019
(REVISED) AIDS-related deadline:  March 22, 2019
Expiration date:  March 23, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-18-020.html

 

NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional) PAR-18-021
Purpose: supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.  
Remaining Deadlines: February 26, 2019; June 28, 2019; October 25, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-18-021.html

 

NCI Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) PAR-18-654
encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities.
Remaining Deadlines:June 18, 2019; November 19, 2019; June 18, 2020; November 19, 2020
https://grants.nih.gov/grants/guide/pa-files/PAR-18-654.html

 

NCI Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) PAR-18-655
R21-exploratory/development award mechanism
Purpose: encourages grant applications from investigators interested in conducting basic research studies into the biological/genetic causes and mechanisms of cancer health disparities.
Remaining Deadlines: June 18, 2019; November 19, 2019; June 18, 2020; November 19, 2020
https://grants.nih.gov/grants/guide/pa-files/PAR-18-655.html

NCI Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) PAR-18-654
Purpose: encourages grant applications from investigators interested in conducting basic research studies into the biological/genetic causes and mechanisms of cancer health disparities.
Remaining Deadlines: June 19 2018; November 19, 2018; June 18, 2019; November 19, 2019; June 18, 2020; November 19, 2020
https://grants.nih.gov/grants/guide/pa-files/PAR-18-654.html





 

NIH national Cancer institute (NCI) K Career development awards

 


Steps to take

See the K award resource webpage >> for steps to take.
All postdoctoral fellows are also required to sign up for one 3-hour computer lab session offered prior to each standard deadline. Those lab sessions will be posted on the above webpage.

Citizenship:
By the time of award, all K award applicants must be a citizen or a non-citizen national of the United States or have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status).


Citizenship Exception: NIH K99/R00 award only : U.S. citizenship or permanent residency is required for all K awards except for the K99/R00 postdoc-to-faculty transition award>>

Visa Information. The K99/00 allows for an applicant to be on a visa that allows them to remain in the country long enough to complete the research project. If you have questions on your visa or status, have your department administrator contact the Bechtel International Center >>. You can also check the Visas for Postdoctoral Scholars Office of Postdoctoral Affairs webpage >> or the DoResearch website Research Policy Handbook RPH 10.3 >> on Postdoctoral Scholars for more information.

 

NCI K01 Research Scientist awards

NCI Mentored Research Scientist Development Award to Promote Diversity (K01-Independent Clinical Trial Not Allowed) PAR-18-364
National Cancer Institute
The intent of this K01 program is to support cancer research scientists in their early career stages. Candidates must have completed at least two, but usually not more than five years of postdoctoral training at the time of submitting a K01 application. However, factors such as family care responsibilities, illness, change of scientific discipline, and active duty military service that may have affected one’s scientific advancement or productivity could be considered for determination of eligibility for the candidates with more than the five year maximum.
Note: this FOA  is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.
Citizenship: The individual must be a citizen or a non-citizen national of the United States or permanent resident.
Standard K award deadlines: Feb. 12, June 12, Oct. 12
Expiration date: Jan. 8, 2021
Program announcement:
http://grants.nih.gov/grants/guide/pa-files/PAR-18-364.html

 

NCI Mentored Research Scientist Development Award to Promote Diversity (K01-Clinical Trial Required) PAR-18-365
National Cancer Institute
The intent of this K01 program is to support cancer research scientists in their early career stages. Candidates must have completed at least two, but usually not more than five years of postdoctoral training at the time of submitting a K01 application. However, factors such as family care responsibilities, illness, change of scientific discipline, and active duty military service that may have affected one’s scientific advancement or productivity could be considered for determination of eligibility for the candidates with more than the five year maximum.
Note: this FOA is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development.
Citizenship: The individual must be a citizen or a non-citizen national of the United States or permanent resident.
Standard K award deadlines: Feb. 12, June 12, Oct. 12
Expiration date: Jan. 8, 2021
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PAR-18-365.html

 

NCI K08 Clinical Scientist RFPs

 

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required) (PAR-18-336)
National Cancer Institute
This FOA for investigators with clinical doctoral degrees from backgrounds nationally underrepresented in the biomedical, clinical, behavioral, and social sciences (see eligibility for additional information).
Note: this FOA is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development.
Citizenship: The individual must be a citizen or a non-citizen national of the United States or permanent resident.
Standard K award deadlines: Feb. 12, June 12, Oct. 12
K award resource webpage (which includes 3-hour computer lab sessions offered in Dec. & Jan.)
http://grants.nih.gov/grants/guide/pa-files/PAR-18-336.html

 

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials) (PAR-18-337)
National Cancer Institute
This FOA for investigators with clinical doctoral degrees from backgrounds nationally underrepresented in the biomedical, clinical, behavioral, and social sciences (see eligibility for additional information).
Citizenship: The individual must be a citizen or a non-citizen national of the United States or permanent resident.
Note: this FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.
Standard K award deadlines: Feb. 12, June 12, Oct. 12
http://grants.nih.gov/grants/guide/pa-files/PAR-18-337.html

 

 

NCI K22-career transition (postdoc-to faculty) awards

 

The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) (PAR-18-466)
National Cancer Institute
This provides protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position.
This FOA is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development
Standard K award Deadlines: Feb. 12, June 12, Oct. 12
Expiration: March 13, 2021
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PAR-18-466.html

 

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) (PAR-18-467)
National Cancer Institute
This provides protected time through salary and research support for the initial 3 years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position.
This is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial.
Standard K award Deadlines: Feb. 12, June 12, Oct. 12
Expiration: March 13, 2021
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PAR-18-467.html

 



NCI K22-career transition (postdoc-to-faculty) awards to promote diversity

 

NCI Transition Career Development Award to Promote Diversity (K22- No Clinical Trials) PAR-18-366
National Cancer Institute
To assist a postdoctoral fellow's transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist. This FOA invites applications from research scientists in postdoctoral positions or equivalent who are from backgrounds underrepresented in biomedical, behavioral, clinical, and/or social sciences.
Note: this FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by another investigator.
Standard K award Deadlines: Feb. 12, June 12, Oct. 12
Expiration date: Jan. 8, 2021
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PAR-18-366.html

 

 NCI Transition Career Development Award to Promote Diversity (K22-Clinical Trial Required) PAR-18-367
National Cancer Institute
To assist a postdoctoral fellow's transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist. This FOA invites applications from research scientists in postdoctoral positions or equivalent who are from backgrounds underrepresented in biomedical, behavioral, clinical, and/or social sciences.
Note: this FOA is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development.
Standard K award Deadlines: Feb. 12, June 12, Oct. 12
Expiration date: Jan. 8, 2021
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PAR-18-367.html

 

 

*Parent K99/R00 awards*

NIH Pathway to Independence Award (Parent K99/R00-Clinical Trial Required) PA-18-397
NCI is one of the multiple participating institutes
This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.
Individuals who need a longer period of mentored career development before they are prepared to begin the transition to research
independence should consider the K08 or K23 program
Citizenship- There is no citizenship requirement. An applicant may be a citizen or a non-citizen national of the United States, have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status), or be a non-U.S. citizen. (See the comments below >>).
Standard K award deadline: Feb. 12, June 12, Oct. 12
Standard K award resubmission deadlines: March 12, July 12, Nov. 12
Standard AIDS-related deadlines: May 7, 2018, Sept. 7, 2018, Jan. 7, 2019, etc.
Expiration date (extended):   Jan. 8, 2021
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-397.html
Questions about your eligibility? Contact the relevant NIH institute contact person per the webpage:
https://grants.nih.gov/grants/guide/contacts/parent-K99-CT-required.html
Institutional representatives-postdocs: Please alert your Research Process Manager (RPMs in RMG >> asap about your plans to submit a proposal so he/she can help build your budget, etc.


NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) PA-18-398
NCI is one of the multiple participating institutes
This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.
Individuals who need a longer period of mentored career development before they are prepared to begin the transition to research
independence should consider the K08 or K23 program
Citizenship- There is no citizenship requirement. An applicant may be a citizen or a non-citizen national of the United States, have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status), or be a non-U.S. citizen. (See the comments below >>).
Standard K award deadline: Feb. 12, June 12, Oct. 12
Standard K award resubmission deadlines: March 12, July 12, Nov. 12
Standard AIDS-related deadlines: May 7, 2018, Sept. 7, 2018, Jan. 7, 2019, etc.
Expiration date (extended):   Jan. 8, 2021
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-398.html
Questions about your eligibility? Contact the relevant NIH institute contact person per the webpage:
https://grants.nih.gov/grants/guide/contacts/parent-K99-CT-not-allowed.html
Institutional representatives-postdocs: Please alert your Research Process Manager (RPMs in RMG >> asap about your plans to submit a proposal so he/she can help build your budget, etc.

 

 


New NIH NCI K99/R00 FOAs for outstanding early stage postdocs

For the following two new NIH NCI K99/R00 postdoc-to-faculty program announcements, applicants must have no more than 2 years of postdoctoral research experience as of the application due date.   These are designed for outstanding postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees.

NIH NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) (RFA-CA-19-029)
National Cancer Institute
This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. Researchers in the scientific areas of data science and cancer control science are especially encouraged to apply.    
This FOA is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.
Eligibility:   For this RFA, K99/R00 applicants must have no more than 2 years of postdoctoral research experience as of the application due date. Individuals must be in mentored, postdoctoral training positions to be eligible to apply to the K99/R00 program. If an applicant achieves independence (i.e., any faculty or non-mentored research position) before a K99 award is made, neither the K99 award, nor the R00 award, will be issued.
Citizenship: There is no citizenship requirement for K99 applicants. An applicant may be a citizen or a non-citizen national of the United States, have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status), or be a non-U.S. citizen.
Application Receipt Date(s): February 26, 2019
Program announcement:
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-029.html
Institutional representative for all SoM PIs:  Research Process Managers in the Research Management Group (RPM assignment webpage >>)

 

NIH NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) (RFA-CA-19-030)
National Cancer Institute
This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. Researchers in the scientific areas of data science and cancer control science are especially encouraged to apply.    
This FOA is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, as part of their research and career development.
Eligibility:    For this RFA, K99/R00 applicants must have no more than 2 years of postdoctoral research experience as of the application due date. Individuals must be in mentored, postdoctoral training positions to be eligible to apply to the K99/R00 program. If an applicant achieves independence (i.e., any faculty or non-mentored research position) before a K99 award is made, neither the K99 award, nor the R00 award, will be issued.
Citizenship: There is no citizenship requirement for K99 applicants. An applicant may be a citizen or a non-citizen national of the United States, have been lawfully admitted for permanent residence (i.e., possess a currently valid Permanent Resident Card USCIS Form I-551, or other legal verification of such status), or be a non-U.S. citizen.
Application Receipt Date(s): February 26, 2019
Program announcement:
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-030.html
Institutional representative for all SoM PIs:  Research Process Managers in the Research Management Group (RPM assignment webpage >>)

 

 

 









Footer Links: